By reprogramming cells from a patient to yield induced pluripotent stem cells, scientists and clinicians can wield a fertile and versatile resource for personalizing patient healthcare via regenerative medicine, cell therapy or disease modeling for drug testing.
Read the full article at: https://engineering.wisc.edu/news/label-free-imaging-plus-data-science-means-better-quality-control-for-biomanufacturing-stem-cells/